Category: ACN Newswire

Financial Highlights:- In 2024, the total revenue amounted to RMB5,261 million, representing a YoY increase of 25.1% - The revenue of the 4Paradigm Sage AI Platform (the “Sage AI Platform”) business grew by 46.7% YoY to RMB3,676 million, accounting for 69.9% of the total revenue - The SHIFT Intelligent Solutions business recorded revenue of RMB1,022 million, accounting for 19.4% of the total revenue - The revenue of the 4Paradigm SageGPT AIGS Services segment amounted to RMB563 million, accounting for 10.7% of the total revenue- Gross profit was RMB2,245 million, with a gross profit margin of 42.7%- The total R&D expenses reached RMB2,170 million, accounting for 41.2% of revenue- The annual loss attributable to the owners of the Company was RMB269 million, with a reduction of RMB640 million compared to the full year of 2023, narrowing by 70.4% YoY. This marks the fourth consecutive fiscal year of sequential loss reduction since 2021Operation Highlights:- In 2024, the number of lighthouse users served by the Company reached 161, a YoY increase of 16%. The average revenue per lighthouse user was RMB19 million, with a Net Dollar Expansion Rate (NDER) of 110% for lighthouse users in 2024- 4ParadigmSage: During the Reporting Period, the Company launched the vertical world model development and management platform, Sage AI Platform 5.0, and completed multiple minor version upgrades, achieving end-to-end capabilities across the computing layer, platform layer, model layer, and application layer- 4Paradigm SHIFT: During the Reporting Period, the Company launched multiple solutions targeting various application scenarios and continued to update and iterate the functionalities and effectiveness of existing solutions to meet enterprise requirements for accuracy, reliability, and real-time performance in different vertical scenarios- 4Paradigm AIGS: During the Reporting Period, the Company continued to upgrade and optimize the functionality and application performance of products, such as the enterprise software reconfiguration assistant AIGS Builder and the enterprise programming assistant AIGS CodeX, creating an enterprise-level “development assistant” that understands customers, businesses, knowledge and R&D, while enabling fast coding capabilitiesHONG KONG, Apr 1, 2025 - (ACN Newswire via SeaPRwire.com) - A leading enterprise AI software company - Beijing Fourth Paradigm Technology Co., Ltd. (“Fourth Paradigm” or the “Company”, Stock Code: 6682.HK) today announced the consolidated annual results for the year ended December 31, 2024 (the “Reporting Period”).In 2024, Fourth Paradigm achieved strong growth in its overall business. The Company’s total revenue reached RMB5,261 million, representing a YoY increase of 25.1%. Gross profit was RMB2,245 million, with a gross profit margin of 42.7%. The Company highly values technological R&D, and has clear profitability goals. During the Reporting Period, the R&D expenses reached RMB2,170 million, accounting for 41.2% of revenue. The annual loss attributable to the owners of the Company was RMB269 million, with a reduction of RMB640 million compared to the full year of 2023, narrowing by 70.4% YoY. This marks the fourth consecutive fiscal year of sequential loss reduction since 2021.In 2024, Fourth Paradigm committed to creating value for customers, continuously enhancing digital transformation experience for existing customers and increasing user stickiness. During the Reporting Period, the number of lighthouse users served by the Company reached 161, a YoY increase of 16%. The average revenue per lighthouse user was RMB19 million, with a Net Dollar Expansion Rate (NDER) of 110% for lighthouse users in 2024.Benefiting from the surge in AI market demand, the Company’s Sage AI Platform business achieved significant growth, driving steady performance improvement of core business. In March 2024, Fourth Paradigm launched Sage AI Platform 5.0, which integrates vertical world model development and management, enterprise AI agent application suites, GPU resource pooling and other end-to-end capabilities, supporting the large-scale production and application of vertical world models and enterprise AI agents, and continuously driving intelligent transformation and high-quality development across industries.Core business revenue increased by 46.7%, with scaled expansion driving rapid businessAs the core of the Fourth Paradigm’s all businesses, the 4Paradigm Sage AI Platform business achieved significant growth during the Reporting Period, with revenue reaching RMB3,676 million, representing a YoY increase of 46.7% and accounting for 69.9% of total revenue. Scale effects are deepening progressively.In 2024, Fourth Paradigm remained committed to technological innovation, comprehensively enhancing the capabilities of Sage AI Platform. On the basis of end-to-end capabilities across the computing layer, platform layer, model layer, and application layer, Sage AI Platform continued to optimize key capabilities such as AI agent and GPU resource pooling. Among these, AI agent further enhanced its ability to solve complex problems and improve execution accuracy, and developed the enterprise AI agent development platform that covers the entire lifecycle of AI agent design, development, debugging, deployment, operational analysis, and iterative optimization. This empowers enterprise developers to efficiently and scalably build business AI agents with cognitive, decision-making, and execution capabilities – all on demand. As a result, development cycles have been reduced by over 95% in most cases. The GPU resource pooling capability enables enterprises to achieve platform-level management of hardware clusters, on-demand allocation of computing resources, and rapid scheduling, helping to address challenges such as low utilization of heterogeneous computing resources and high costs of adapting large models to computing power. According to the latest report from the internationally authoritative research firm IDC, Fourth Paradigm has maintained its position as the leader in China’s machine learning platform market share for six consecutive years.While scaling its core business, Fourth Paradigm has also made steady progress in its two other major businesses – SHIFT Intelligent Solutions business and 4Paradigm AIGS service business, which provide strong support for the core business – Sage AI Platform, driving efficient growth across the overall business.During the Reporting Period, revenue from SHIFT Intelligent Solutions totaled RMB1,022 million, comprising 19.4% of the total revenue. This business is built on the Sage AI Platform, tailored to different industry business scenarios. These solutions enable Fourth Paradigm’s technology and capabilities to penetrate a wider range of industries and scenarios, addressing critical business challenges for traditional enterprises and driving digital and intelligent transformation across industries. Due to the impact of the business expansion strategy, the revenue from this business decreased by 20.3% YoY while the revenue from Sage AI Platform business achieved 46.7% YoY growth.In addition, the revenue from the 4Paradigm SageGPT AIGS Services business during the Reporting Period reached RMB563 million, accounting for 10.7% of the Company’s total revenue. This business provides efficient development tools and services based on generative AI for the Sage AI Platform business, enabling multi-fold increases in enterprise R&D productivity.“AI agent + Vertical World Model” dual-core architecture builds the AGI foundation, enabling continuous expansion of the business ecosystemIn recent years, the continuous advancement of generative AI technologies has accelerated progress toward Artificial General Intelligence (AGI), a consensus widely recognized across the industry. As an enterprise with over a decade of experience in the AI sector, Fourth Paradigm is committed to empowering industries through its core philosophy of “AI agent + Vertical World Model”, which uses AI agents to understand human needs and leveraging corresponding vertical world models to solve problems, while continuously enhancing their respective capabilities – will ultimately drive the realization of AGI.Over the past year, adhering to the philosophy of “AI agent + Vertical World Model”, Fourth Paradigm has collaborated with numerous industry partners and has successfully implemented hundreds of reliable and controllable enterprise-level AI agent applications, covering scenarios such as financial credit risk control, water and electricity equipment maintenance, hydrological data monitoring, chronic disease management, intelligent course learning, automotive manufacturing MES system management, fluid dynamics design, intelligent after-sales customer service and academic administration assistant, comprehensively driving the intelligent transformation for enterprises.At the same time, Fourth Paradigm, in collaboration with partners, has released several out-of-the-box user-level agent solutions, such as intelligent meeting solutions, intelligent mouse solutions, and desktop AI search tools. These solutions cover AI agent capabilities such as simultaneous interpretation, one-click translation, robotic assistants, AI writing, and intelligent cross-platform search, helping enterprise business personnel achieve a leap in daily work efficiency.In addition, since the advent of DeepSeek, the inference and deployment costs of large models have significantly decreased, catalyzing market demand across large model implementation, integrated solutions deployment, and on-device AI applications. Fourth Paradigm has rapidly iterated its technical capabilities and product adaptations to deliver high-value solutions addressing these market needs.In terms of integrated solutions, Fourth Paradigm launched the out-of-the-box SageOne IA large model inference integrated solution, which enables seamless switching between the full-capacity model and multiple distilled models while supporting mainstream large models. This increases GPU utilization by over 30% and improves inference performance by an average of 5-10 times. Furthermore, SageOne IA comes with a rich suite of AI applications, helping developers efficiently create enterprise-level generative AI applications.For on-device AI, Fourth Paradigm launched the ModelHub AIoT on-device inference solution. This solution allows users to easily deploy small-sized distilled models such as DeepSeek R1, Qwen 2.5, and Llama 2/3 series on on-device devices for offline operation. It also balances model compression and inference performance while addressing the complexities of deployment and optimization. In addition, the Company has further expanded these capabilities into the consumer electronics sector, delivering AI Agent solutions that integrate hardware and software. That empowers consumer electronics manufacturers to launch AI-enabled terminal products that resonate with their users.In terms of Strategic Outlooks, Dr. Dai Wenyuan, Chairman of the Board, Executive Director, Chief Executive Officer and General Manager of Beijing Fourth Paradigm Technology Co., Ltd. said, “In recent years, generative AI has gained widespread recognition globally. As an AI technology service provider with over a decade of experience in the enterprise service sector, we have a deeper and more accurate understanding of how to organically integrate these rapidly evolving AI technologies to empower our enterprise clients, create tangible business value, and deliver practical efficiency improvements for both enterprises and individuals. This aligns with our ultimate vision that has always guided our business – AI for Everyone. Looking ahead, we will build on our decade-long expertise in the enterprise service sector, look toward the broader AI market, and leverage our AI capabilities to transform all possible business domains. We believe that the convergence of these diverse capabilities will form the cornerstone for achieving AGI.” Copyright 2025 ACN Newswire via SeaPRwire.com.

Marrakech, Morocco, Apr 8, 2025 - (ACN Newswire via SeaPRwire.com) - Morocco WEB3FEST GITEX Edition, a global conference series focused on technology and innovation in AI, Blockchain, and sustainability, organized by InactaVentures and co-hosted by The Hashgraph Association, being carried out in Marrakech, Morocco from April 14-16, 2025 is set to bring together the world’s foremost Web3 leaders, innovators, and investors at the intersection of technology, finance, and sustainability. Hosted in Marrakech during GITEX Africa, this premier event serves as a critical bridge linking the vibrant ecosystems of Africa, the Middle East, and Europe.With a strong commitment to advancingdecentralized technologies and sustainable innovation, Morocco WEB3FEST GITEX Edition is poised to drive meaningful dialogue and collaboration among industry pioneers, enterprises, and policymakers.What is the WEB3FEST?WEB3FEST is a global conference series focused on technology and innovation in AI, Blockchain and Sustainability. It serves as a vibrant hub where companies across the value chain – from agile startups to international corporations – converge to share ideas, build networks, and shape the future of the industry.Kamal Youssefi - President of The Hashgraph Association noted, “We are honored to be co- hosting the WEB3FEST in Morocco during GITEX Africa given that one of the aims of THA is to empower entrepreneurs, enterprises and governments with the technologies and knowhow needed to foray into Web3 while keepingsustainability at the heart of their endeavors. This is why Hedera network, considered one of the most sustainable in the world, is at the center of our conversations.”Ralf Glabischnig – Founder of Inacta Ventures, added, "Switzerland has always been a hub for Blockchaininnovation, and our Layer 1 technology is solving real-world challenges in developing countries. With Morocco as the perfect gateway to Africa, we are connecting European expertise with Africa’s immense potential for Blockchain adoption."Event Highlights:The Green Block TalksApril 14, 2025Sofitel Marrakech Palais ImperialA high-impact evening bringing together thought leaders and industry experts to discuss the role of AI and Web3 in driving sustainability. Featuring insightful panels, networking opportunities, and meaningful discussions.Featured Speakers:Ian Putter – Head of Blockchain COE, Standard BankTom Rieder – Director Marketplace, The Green BlockAbdelaziz Benyahya – Chief Transformation Officer, AXA MoroccoKamal Youssefi – President of The Board, The Hashgraph AssociationRalf Glabischnig – Founder, Inacta VenturesWEB3 Investor Dinner (Co-hosted by NEO AI)April 15, 2025Private Villa, MarrakechAn exclusive, invitation-only gathering for venture capitalists, fund managers, and private equity professionals.This intimate setting will facilitate high-level discussions on investment opportunities, portfolio strategies, and the evolving digital asset landscape.About the Organizer Inacta VenturesAt the helm of the WEB3 revolution, Inacta Ventures builds ecosystems, ventures, and smart capital strategies.With operations in the thriving Crypto Valley in Switzerland and the Crypto Oasis in the UAE, Inacta empowers over 100 portfolio companies and enterprises to scale groundbreaking WEB3 solutions.About the Co-Host The Hashgraph AssociationThe Hashgraph Association, a Swiss non-profit, drives global adoption of Hedera-powered solutions by funding innovation, training, and venture programs. It promotes economic inclusion and a digital future with a positive ESG impact. https://www.hashgraph.swiss/aboutRegistrationReserve your spot now and join the world’s brightest minds to shape the future of WEB3: Register HereFor more details, visit: web3fest.chContact:Fabio SchlafHead of Ecosystem Development Inacta Ventures & Crypto Oasis fabio.schlaf@inactaventures.com Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年4月7日 - (亚太商讯 via SeaPRwire.com) - 在经历了1972-1980年、2002年-2012年两轮牛市后，2019年8月1日，美联储十年来首次降息，海外央行纷纷跟进放水，以及国际地缘政治日趋复杂等因素扰动下，美元信用逐渐走弱，作为避险资产的黄金显现独特价值，步入第三轮牛市。持续至今的黄金大牛市下，处于产业链上游的金矿企业无疑是最大受益者之一，不仅表现在产能扩张、业绩增长上，也体现在股价的持续拉升上。港股黄金开采板块中，截至今年3月31日，万国黄金集团（03939.HK）自去年3月以来累计上涨214.46%，近两年的涨幅更超过7倍，领涨整个板块，更远远跑赢大盘。股价能有如此强势表现，得益于万国黄金集团主业转型的成功。同时，公司还于3月10日起进入港股通，流动性获得大幅提升，股价亦再创新高，3月20日盘中创下18.36港元的历史最高点。被纳入港股通标的以来，公司获南下资金持续增持，截至3月底，港股通持股比例增至1.41%，持股市值2.42亿港元。收购金岭矿实现主业转型，迈入高潜力增长新阶段万国黄金集团原名"万国国际矿业"，主要在中国及所罗门群岛从事采矿、矿石选矿及销售精矿产品业务，在2023年之前，一直以旗下新庄矿的精矿产品为主要收入来源，而自2023年之后，金岭矿的收入规模逐渐超过新庄矿，位居第一。出于对黄金走牛趋势的精准预判，万国黄金集团早于2020年4月30日收购了祥符金岭有限公司的77.78%权益，而后者拥有位于所罗门群岛的一处金岭矿90%权益，并于2022年11月起开始试产。整个2023年是金岭矿的产能爆发之年，全年实现收入约人民币6.58亿元，一举超过新庄矿约人民币5.73亿元的总营收，占万国黄金集团总营收的比重提升至50.1%，成为公司第一大收入来源。也正因为金岭矿的产能扩张，使得万国黄金集团2023年业绩大增，收入、归母净利润分别增长93.0%、85.8%。2024年上半年，公司收入、归母净利润继续保持快速增长，增速达59.7%、72.9%，其中金岭矿收入占比进一步提升至约60.5%。看到如此良好势头，公司也趁热打铁，于2024年10月9日完成收购祥符金岭额外20.22%权益，由此拥有祥符金岭的98%权益及金岭矿的88.2%实际权益，将"金岭矿"这一聚宝盆牢牢攥在手中。事实证明，这一策略是极为正确的。随着勘探项目的不断推进及生产工艺的循序改进，金岭矿销量持续提升，使得万国黄金集团的第一大收入来源发生了改变，更名成为水到渠成之事。2024年8月6日起，公司名称正式由原来的"万国国际矿业集团有限公司"更改为"万国黄金集团有限公司"，以全新的企业定位和品牌形象，踏上跨越式发展的快车道。2024年度，核心主营业务升级为黄金开采及销售的万国黄金集团，业绩继续稳步提升。全年实现收入约人民币18.76亿元，同比增加42.6%，其中，来自金岭矿的收入同比增加80.4%，占比63.3%。整体毛利约人民币9.97亿元，同比增加61.0%，整体毛利率53.2%；金岭矿毛利同比增加98.1%，毛利率55.6%，高出整体毛利率2.4个百分点。公司归母净利润约人民币5.75亿元，同比增加71.6%。以上数据可以看出，金岭矿无论是收入、毛利润增幅，还是毛利率，都要高于万国黄金集团的整体水平，对增厚公司盈利产生的引擎作用明显。这也从侧面说明了，公司审时度势，顺应本轮黄金牛市而进行主业转型，经受住了市场的考验。产能爬坡提速进行时，机构看好业务发展前景从投产过程来看，万国黄金集团旗下金岭矿于2022年8月开始堆浸厂试生产，并从2023年1月1日开始浮选厂试生产。于此试产阶段，金岭矿的浮选精矿产量一直在稳步提高，接近其设计产能。根据公司披露，截至2023年12月31日，金岭矿的矿产资源总量为7,200万吨（含金量330万盎司），储量为2,870万吨（含120万盎司黄金）。公司发布的最新数据显示，截至2024年7月31日，金岭矿的矿产资源总量为1.96亿吨（含金量730万盎司），较2023年底增幅分别为172.2%及121.2%。储量为3,070万吨（含130万盎司黄金），较2023年底增加7.0%和8.3%。根据业绩报告，于2024年，金岭矿的采矿量约271.3万吨，同比增加85.0%；选矿量约228.1万吨，同比增加96.9%。对此，民生证券在最新研报中指出，以20年左右的矿山生命周期来预估，未来金岭金矿年产量或能达到10吨以上，成长空间广阔。该行认为，万国黄金集团未来成长空间广阔，随着公司采矿恢复正常，选矿逐步改善，当前产能爬坡预计提速，同时未来还有进一步扩产的可能，叠加金价景气，看好公司后续黄金产量持续增长，迎来量价齐升。中信证券则认为，目前金岭矿项目技改阶段正处于爬坡期，增储落地有望促进项目第二阶段规划和建设，预测金岭矿长期产量潜力有望达到8-10吨/年以上，效益释放正当时，成长前景远大。此外，金岭矿收购的资源对价仅为行业平均水平的三分之一，叠加规模效应以及电力供应改善，成本优势有望进一步夯实。该行预计2025年量增、降本、价涨的延续，将促进万国黄金集团业绩延续快速增长，近期金岭矿资源翻倍式增长为中长期扩产提供支撑，给予公司2015年17倍PE估值，首次覆盖并给予公司"买入"评级，目标价20港元。获纳入恒指及港股通，长期投资价值持续彰显近期，除了2024年度业绩报喜，万国黄金集团还获纳入恒生综合指数，并成为港股通标的，预示着其未来发展将迎来诸多利好。今年2月21日，恒生指数公司公布最新季检结果，其中万国黄金集团满足了包括市值、流动性和上市时间等在内的一系列标准，获纳入恒生综合指数成份股。其后，根据深圳证券交易所公告，因应恒生综合指数成份股定期调整，深港通下的港股通标的证券名单于2025年3月10日起实施重大调整，万国黄金集团获调入，进入港股通名单。被纳入恒指，是资本市场对万国黄金集团长期投资价值的高度认可。恒生指数作为香港市场的重要风向标，其成分股的选择极为严苛，需综合考量公司的市值规模、财务状况、行业地位以及发展前景等多方面因素。公司能够脱颖而出，成为其中一员，充分证明了其在黄金产业领域的稳健实力，以及在业务拓展过程中所展现出的强大竞争力和可持续增长潜力。进入港股通后，万国黄金集团能够显著扩大股东基数，提升公司在国际资本市场的知名度和影响力，进而吸引更多长期稳定的投资者成为公司股东，为公司发展提供坚实的资金保障。同时，有助于吸引更多专业投资者和交易机构参与其股票交易，从而有效改善公司股票的流动性。此外，这也为公司带来了大量的主动和被动配置机会，这些新增的资金配置将为公司发展注入强劲动力。良好的市场表现与资金支持，往往会带来更优的估值待遇。随着万国黄金集团在资本市场的知名度提升、股东基数扩大、流动性增强以及资金配置增加，市场对公司的未来发展预期将进一步提高，使公司享受更高的估值溢价。更高的估值不但意味着公司市值的提升，还将增强公司在融资、并购等方面的优势，为公司实现更大规模的发展和战略布局创造有利条件。多重利好加持，让万国黄金集团站在了牛市的风口之上。在全球货币超发、国际局势多变以及"去美元化"浪潮下，凭借稀缺性和长期储藏性，黄金中长期依旧具备较高的配置价值。通过在黄金产业领域持续深耕，不断创新发展，相信万国黄金集团将以"盈利增长"和"估值提升"双重驱动，为投资者带来超额回报。 Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Apr 3, 2025 - (ACN Newswire via SeaPRwire.com) - JBM (Healthcare) Limited (“JBM Healthcare”; Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, announced today that it has acquired a 90% stake in Tin Hee Tong Medicine Factory, Limited (“Tin Hee Tong”,), at a total consideration of HK$171.0 million. Tin Hee Tong has now become a non-wholly owned subsidiary of JBM Healthcare.Strengthening the Portfolio with a Trusted Heritage BrandTin Hee Tong’s flagship product, Tin Hee Tong Tin Hee Pills, has a rich legacy and strong brand recognition across Hong Kong and Mainland China, particularly in Guangdong Province. The product is well formulated for regulating the female menstrual cycle, promoting reproductive health, and enhancing blood circulation for a radiant complexion. Tin Hee Tong Tin Hee Pills is a highly trusted brand for gynecological well-being among female consumers. Recognising its distinctive market position and long-term growth potential, the Group sees this acquisition as a valuable strategic fit for its proprietary Chinese medicines portfolio.Unlocking Growth Potential & SynergiesThe acquisition presents a compelling opportunity to expand the Group’s portfolio of proprietary Chinese medicines and accelerate its growth strategy. By integrating this iconic brand into its existing lineup, the Group is well-positioned to capitalise on rising consumer demand for holistic healthcare solutions.To maximise the brand’s potential, the Group plans to launch a comprehensive marketing campaign, leveraging its extensive expertise in brand management and revitalisation to boost consumer awareness and engagement. Additionally, the Group will expand distribution networks to capitalise on new market opportunities and customer segments. By combining the complementary strengths of both businesses, the acquisition is expected to generate significant synergies, reinforcing the Group’s strategy of acquiring assets that align with its long-term vision and create shareholders’ value.Proven Track Record in Brand RevitalisationThe Group has a proven track record of revitalising heritage proprietary medicines brands, effectively transforming legacy products into prominent market players. Its portfolio includes iconic brands such as Po Chai Pills — a market leader in proprietary Chinese gastrointestinal medicines, Ho Chai Kung — a widely recognised household name in the OTC pain killer category, and Flying Eagle Woodlok Oil — a rejuvenated brand in the traditional Chinese medicated oil sector, driven by creative advertising that blends Hong Kong nostalgia with broad consumer appeal.Through strategic brand revitalisation, omni-channel expansion, and digitally driven consumer engagement strategies, the Group has successfully transformed heritage brands into contemporary wellness solutions that resonate with both loyal customers and the younger, generations. With Tin Hee Tong Tin Hee Pills, JBM Healthcare is set to reinvigorate this trusted brand and expand its market presence.Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare said, “The acquisition of Tin Hee Tong represents a pivotal step in strengthening our leadership in the proprietary Chinese medicines sector. With its rich heritage and strong recognition, Tin Hee Tong Tin Hee Pills is a highly complementary addition to our portfolio. Drawing on our proven brand revitalisation expertise, we are confident in unlocking its full growth potential and delivering long-term value to our shareholders.”About JBM (Healthcare) Limited; Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills , Ho Chai Kung Tji Thung San , Tin Hee Tong Tin Hee Pills , Flying Eagle Woodlok Oil , Tong Tai Chung Woodlok Oil , Shiling Oil , Konsodona Medicated Oil , Contractubex and Mederma for Kids . JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

TAIPEI, TW, Apr 8, 2025 - (ACN Newswire via SeaPRwire.com) - In a feature recently published by The Icons, Taiwanese artist Grace Tan is recognized for redefining the language of traditional ink art through a contemporary, multi-sensory approach. A master of calligraphy and seal carving, Tan seamlessly blends Eastern aesthetics with Western structures, transforming brush, ink, and rhythm into a vivid cross-cultural dialogue.Rooted in the rich cultural heritage of Taiwan, Grace Tan views art as a universal language - one that speaks beyond technique and form. "Art is the language of the soul," she explains. "Its power lies in whether it can create a resonance - a rhythm that connects deeply with others."Her artistic practice is deeply influenced by music, particularly her study of the pipa, a traditional Chinese instrument. She describes her brushwork as a visual form of music, where ink density, stroke pressure, and spatial pauses mirror tempo, pitch, and silence in a musical composition. Her compositions are at once lyrical and structured, poetic yet dynamic.Through innovative techniques such as layering, geometry, and the use of lightboxes, Tan creates an immersive visual-musical experience. Her artworks are not static; they shift in response to lighting and perspective, offering viewers a real-time encounter with rhythm, space, and emotion.As a Taiwanese artist active on the international stage, Grace Tan has exhibited in France, the United States, Japan, and South Korea. Her works are housed in the permanent collections of the World Bank Headquarters, the American Academy of Asian Culture, the San Francisco Public Library, and the University of Cyprus - testament to her growing global impact.Grace Tan composes with ink and lets her lines sing, transforming calligraphy, seal carving, and visual art into vessels of musical expression. From the interplay of geometry and colour, to the rhythmic flow of brushstrokes and the carefully composed cadence within her seal designs, her work reflects a profound exploration of "rhythmic writing." The dryness or fluidity of ink, the tension and release of each line, and the thoughtful use of negative space resemble the dynamics and pauses found in musical composition - all weaving together into her own distinctive artistic tapestry. (Photography: Grace Tan)Her artistic voice carries particular resonance for European audiences, who appreciate her thoughtful fusion of East and West. By combining the introspective stillness of Eastern philosophy with the expressive freedom of contemporary Western art, she opens a space for cultural reflection and connection.Grace Tan's work is not just a celebration of tradition, but a reimagining of it - offering a vision of art that transcends borders and speaks to the shared human experience. Copyright 2025 ACN Newswire via SeaPRwire.com.

SINGAPORE, Apr 7, 2025 - (ACN Newswire via SeaPRwire.com) - TVS Motor Company (TVSM), a leading global manufacturer of two and three-wheelers, is set to strengthen its electric vehicle (EV) presence in Southeast Asia through the integration of ION Mobility’s assets, intellectual property, and talent into its operations. Southeast Asia represents one of the world’s fastest-growing regions for motorbike usage, offering a significant opportunity for expansion.TVSM has been a strategic investor in ION Mobility, a full-stack EV company known for its robust in-house capabilities across industrial and product design, mechanical and electrical engineering, embedded and power electronics, firmware, software, and supply chain solutions. This integration, combined with TVSM’s deep expertise in electric mobility, marks a major step toward unlocking new possibilities in the region.Commenting on the development, Sharad Mohan Mishra, President Group Strategy, TVS Motor Company, said: “We were an early strategic investor in ION Mobility, attracted by their focus on delivering smart, sustainable, and exciting mobility solutions for ASEAN markets. Our ‘Reimagine 2030’ vision strongly aligned with their mission. With the acquisition of ION Mobility’s assets, IP and core team, we are thrilled to bring their entrepreneurial energy, design thinking and engineering strength into TVSM. Combined with our R&D depth, quality systems, and manufacturing scale, this partnership positions us to accelerate market penetration and grow our share across Southeast Asia.”TVS Motor is already a formidable player in the global EV landscape, with nearly 600,000 customers choosing its flagship electric scooter, TVS iQube. The company has developed end-to-end in-house capabilities across EV components - battery systems, battery management, vehicle control units, and connected platforms - and holds more than 650 patents in the EV domain.Earlier this week, TVS Motor Company announced that its wholly owned subsidiary TVS Motor (Singapore) Pte Ltd acquired select assets from ION Mobility and also divested its stake in the company. Following this move, James Chan, Founder and CEO of ION Mobility, has joined TVS Motor Company as Senior Vice President. He will lead TVSM’s business across ASEAN while also spearheading the development and launch of the M1-S electric mobility platform. The M1-S is already generating strong interest in ASEAN markets for its striking design, impressive range, agile acceleration, and suitability for daily commutes.About TVS Motor CompanyTVS Motor Company (BSE:532343 and NSE: TVSMOTOR) is a reputed two and three-wheeler manufacturer globally, championing progress through sustainable mobility with four state-of-the-art manufacturing facilities located in India and Indonesia. Rooted in our 100-year legacy of trust, value, and passion for customers, it takes pride in making internationally accepted products of the highest quality through innovative and sustainable processes. TVS Motor is the only two-wheeler company to have won the prestigious Deming Prize. Our products lead in their respective categories in the J.D. Power IQS and APEAL surveys. We have been ranked No. 1 Company in the J.D. Power Customer Service Satisfaction Survey for four consecutive years. Our group company Norton Motorcycles, based in the United Kingdom, is one of the most emotive motorcycle brands in the world. Our subsidiaries in the personal e-mobility space, Swiss E-Mobility Group (SEMG) and EGO Movement have a leading position in the e-bike market in Switzerland. TVS Motor Company endeavours to deliver the most superior customer experience across 80 countries in which we operate.For more information, please visit www.tvsmotor.com or write to corpcom@tvsmotor.com Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Mar 31, 2025 - (ACN Newswire via SeaPRwire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2024 (the "Reporting Period"). During the year, the Group adhered to its overall business philosophy of “in-depth services and lean operations”, promoted development with innovation, deepened integrated collaboration among “government, industry, academy, research, medicine, application”, accelerated digital application of “AI + medical care”, continuously strengthened refined management, and reduced cost and improved efficiency, demonstrating strong operational resilience.In 2024, due to changes in the macro-environment, intensified competition in the industry as well as its strategic decision to optimize customer structure and product mix, the Group’s performance was temporarily affected. However, relying on its customer-oriented, innovative and coordinated development system, the Group achieved many breakthroughs in product innovation, model innovation, AI + medical digital intelligence and other aspects. The joint construction business with medical institution alliances remained its largest business segment, which accounted for 53.0% of the total revenue, representing an increase of 4.7 percentage points as compared to the same period of the previous year. In addition, featured products in the infection segment achieved rapid growth, laying a solid foundation for the segment’s long-term development. During the Reporting Period, the Group’s total revenue reached RMB711.9 million.Diagnostic testing for medical institution alliances was developing healthily In-depth service empowers customersYunkang is committed to developing an innovative service mode for joint construction of medical institution alliances with “professionalism as the foundation, standardization as the core, digital intelligence as the means, synergization as the goal”. At present, the Group is providing medical technical service solutions to over 1,500 medical institutions in collaboration with medical institution alliances at over 430 on-site diagnostic centers of the alliances to meet their core demands. Through close collaboration – mutual recognition of testing results – with leading regional medical institutions, the Group has helped improve overall regional medical and treatment levels, helping hospitals build specialty departments, improving the efficiency of hierarchical diagnosis and treatment, promoting scientific research and cooperation, etc., thereby providing the public with higher-quality and more efficient diagnosis and treatment services. Dedicated to vigorously driving medical reform in China, during the Reporting Period, Yunkang teamed up with leading provincial-level hospitals, and regional county-level general hospitals to jointly build medical institution alliances to actively promote the construction of medical institution alliances as the bridge that connects the regional testing centers and partner hospitals. Customers are provided with “3+N” tumor, infection, reproductive genetics and +N technical system support, and also support from the in-depth service system, including the operation of diagnostic centers under regional medical institution alliances, access to new technologies or new products, construction services for digital specialty departments, medical cold chain logistics services, quality control services and supply chain services, all in-depth services for empowering demand and the long-term development of hospitals.Focus on “clinical demands” Joint innovation for diagnostic testing achieved remarkable resultsAdhering to the “clinical demands”-oriented service concept, the Group has built a series of high-tech platforms, including high-throughput sequencing, gene chip, high-sensitivity PCR, protein spectrometry, cytogenetics, digital remote pathology, and ultra-micro pathology. During the Reporting Period, the Group introduced nearly 800 new testing items and provided about 3,800 clinical testing items, and more than 10 million specimens were tested for the year. In terms of precision diagnosis and treatment, the Group carried out more than 500 precision diagnosis services using cutting-edge technologies such as high-throughput sequencing, and protein spectrometry, covering five medical fields including infectious diseases, reproductive genetics, solid tumors, blood diseases, and personalized medicine. During the Reporting Period, the Group focused on the construction and development of 58 new items in such fields including infection, tumor, rare genetic diseases and personalized medicine, providing medical institutions nationwide with a more comprehensive range of precision diagnosis solutions to drive the embrace and development of precision medicine. During the Reporting Period, revenue from special testing items increased significantly year-on-year, accounting for a larger percentage of the Group’s overall revenue.The Group has a first-of-its-kind “joint innovation platform for diagnostic testing”, which has played a vital role in expanding its business and boosting competitiveness of its products. Constantly exploring and putting ideas into practice, the Group and dozens of top medical institutions across the country have pursued joint innovation for diagnostic testing and successfully developed more than 10 testing products for different infection syndromes in various fields such as respiratory tract infections and central nervous system infections.Digital application of “AI + medical care” leads the industryThe Group has launched and continuously upgraded its top 10 digital “cloud” systems, covering core areas such as laboratory operations, sales management, human resources, staff training, and customer services. At the same time, it has integrated AI technology into its “cloud” systems to create a one-stop intelligent medical diagnostic solution covering from “sample collection” to “report delivery”, which was comprehensively applied across its multi-technology platforms in medical laboratories, with the core concepts of “Internet+” and “precision diagnosis” to create a series of intelligent diagnostic platforms. In the Reporting Period, the Group’s self-developed digital IT platform with full intellectual property rights – the remote pathology consultation platform – covered over 800 medical testing items, assisting nearly 300 medical institutions nationwide in enhancing their pathology diagnostic capabilities and benefiting more than 200 million patients in rural areas.Regarding the application of AI-assisted diagnosis, the Group adheres to the strategy of “introducing one item once it is mature” and closely follows industry development trends. It has introduced items such as pathological DNA polyploid AI-assisted diagnosis, cervical liquid-based cell AI-assisted diagnosis, and chromosome AI analysis, all proven effective and have greatly enhanced diagnostic efficiency. During the Reporting Period, the Group focused on the field of infectious diseases and developed its first infectious disease data product, the “Yunkang Respiratory Pathogen Detection Positivity Rate Analysis Report”. The product officially obtained data product certification and was listed on the Guangzhou Data Exchange in January 2025, marking a milestone step for the Group in the field of compliant data transactions, effectively unlocking data value. Currently, having access to the DeepSeek large model, the Group aims to achieve comprehensive innovation in medical testing and diagnostics through inclusive technology, precision service and intelligent management.Collaborative and integrated development of “government, industry, academy, research, medicine, application” to facilitate industrial upgradeDuring the Year, the Group collaborated with various institutions to facilitate industrial upgrade based on a unique innovative industrial model, including:- Collaboration with The People’s Government of Ouhai, Wenzhou City and Wenzhou Medical University’s core areas in biomedical industry to promote construction of a number of key projects including a joint innovation and transformation platform, a public service platform, a medical big data research platform, a regional diagnostic sharing center and a training base for innovative talent, to the end of facilitating quick transformation of scientific research results for industrial applications;- Collaboration with The Zhangjiang Research Institute of Fudan University to jointly establish a “Collaborative Innovation and Transformation Center” to promote innovation and transformation of results of medical diagnostic technology application;- Collaboration with The Central University of Finance and Economics, Greater Bay Area Research Institute to jointly build an industry-education fusion talent cultivation highland and an industry aggregation and incubation platform.The strategy for sustainable development drives long-term valueWhile vigorously driving business development, Yunkang has consistently viewed sustainable development as a core strategy of the Group, committed to promoting the green transformation of the healthcare industry through innovative technologies and in-depth services. The Group engaged in environmental protection efforts such as energy conservation, emission reduction, and resource recycling in its operations, while also launched various charitable initiatives, including charitable clinical diagnostic activities, health checkup services for the well-being of the community, and health seminars, to give back to society by making use of its professional advantages. Looking ahead, Yunkang will continue to make progress in ESG and step up our efforts in such areas as environmental policy and management, Scope 3 emissions, climate governance, climate performance indicators, climate scenario analysis, carbon reduction targets, and net-zero emissions commitment, all of which will help us realize economic, environmental and social benefits.Future prospectsChina has continued to promote expansion and downward penetration of the country’s high-quality medical resources, fostering a balanced regional layout and stepping up the construction of a hierarchical diagnosis and treatment system, conducive to establishing close-knit medical institution alliances. China’s Laboratory Developed Testing methods (LDT) pilots have steady and notable progress, leading to market growth for precision medicine development. In addition, in-depth integration of AI technology with the healthcare industry will become an important driving force for fine industry segments to embark on digital intelligence transformation and upgrade. Looking ahead, Yunkang will continue to align with national policies, seize the latest industry development opportunities, and continue to strengthen clinical-empowered value, and constantly explore and deepen the two new “product innovation + model innovation” model with customers in mind and to ensure residents can better benefit from its medical achievements.Yunkang Group Limited（Stock Code：2325）Yunkang Group is a leading medical operation service provider in China, which started to provide standardized medical diagnostic services to medical institutions at all levels as early as 2008. Leveraging its own professional diagnostic capabilities and the nationwide service network of integrated healthcare systems, Yunkang has gradually grown to become a medical operation service platform. Meanwhile, Yunkang is a medical operation service provider in China offering a full suite of diagnostic testing services which are diagnostic outsourcing services and diagnostic testing services for medical institution alliances. Yunkang provides diagnostic services through on-site diagnostic centers to collaborative hospitals in the integrated healthcare systems in China and assists them in improving their clinical diagnosis capabilities through co-developing diagnostic centers. As of today, Yunkang has successfully provided professional services to 430+ on-site diagnostic centers. As of December 31, 2024, the hospitals we collaborated with were located across 31 provinces and municipalities in China. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Apr 4, 2025 - (ACN Newswire via SeaPRwire.com) - Connect Marketplace Hong Kong (CMHK) successfully concluded its preview event in APAC in 2025, marking a significant milestone in fostering business collaboration within the MICE industry. Held from 19-21 March 2025, the event successfully brought together over 4,000 industry professionals, along with more than 60 exhibitors from over 30 countries and regions. It focused on creating an invaluable platform for networking and business development.Margaret Ma Connolly, president and CEO of Informa Markets in Asia, highlighted the event’s role in driving transformation within the MICE industry. “The launch of Connect Marketplace Hong Kong is more than just a new event. It's a testament to our belief in Hong Kong as the ultimate MICE destination. Here at Connect Marketplace Hong Kong, we’re not just discussing the future of business events – we’re actively shaping it, fostering connections that transcend borders and drive economic growth across Asia and beyond” she said.Connect Marketplace Hong Kong excelled as a premier platform for business collaboration, featuring the Hosted Buyer Programme, which brought together around 450 international decision-makers and facilitated close to 1,300 business organised through its innovative one-on-one meeting initiatives.Additionally, conference sessions and forums addressed key industry topics, from sustainability to cutting edge MICE solutions. A series of networking opportunities, including Horse Racing Night, Gala Dinner and a Familiarization Trip to Macau further strengthened interactions among global industry players.Janice Lee, Senior Portfolio Director of Connect Marketplace Hong Kong, expressed excitement for future growth: “This is a remarkable achievement! I have witnessed the spirit of Informa unfold over four months of hard work, culminating in around 4,000 attendees at the show. This success gives us great confidence as we look ahead to the next edition of CMHK in 2026.” The next edition of Connect Marketplace Hong Kong is scheduled for 18-19 March 2026.About Informa MarketsInforma Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.For media enquiries, please contact: cheenie.so@informa.com Copyright 2025 ACN Newswire via SeaPRwire.com.

HIGHLIGHTS:- During the Reporting Period, the Group’s gross billings amounted to approximately RMB3,505.9 million, representing an increase of approximately 49.3% from approximately RMB2,347.7 million for the Corresponding Period.- The total revenue of the Group was approximately RMB2,306.0 million, representing an increase of approximately 17.3% compared to approximately RMB1,965.4 million for the Corresponding Period.- The profit attributable to Shareholders of the Group was approximately RMB272.4 million, representing an increase of approximately 42.8% from approximately RMB190.7 million for the Corresponding Period.- The Group’s operating cash flow (net inflow) was approximately RMB1,627.8 million, representing an increase of approximately 266.6% as compared to approximately RMB444.0 million for the Corresponding Period.- Taking into account the financial and cash flow positions of the Group, the Board recommends the payment of a final dividend of approximately HKD148.0 million for the year ended December 31, 2024, representing HKD0.33 per share (in cash), and the proposed final dividend is subject to consideration and approval by Shareholders at the AGM.HONG KONG, Apr 4, 2025 - (JCN Newswire via SeaPRwire.com) - 28 March, JF SmartInvest Holdings Ltd(the “Company” ; together with its subsidiaries, the "Group" or “we”) is pleased to announce its consolidated annual results for the year ended December 31, 2024 (the “Reporting Period”). During the Reporting Period, the Company realized a revenue of approximately RMB2,306.0 million, representing a growth of approximately 17.3% from the Corresponding Period. Profit attributable to Shareholders amounted to approximately RMB272.4 million, representing an increase of 42.8% over the Corresponding Period. In addition, our operating cash flow was strong. We had a net inflow of approximately RMB1,627.8 million which represented a significant year-on-year growth of 266.6%, fully demonstrating the effective strategy execution and high market adaptability of the Company.Developed a multi-dimensional product structure to promote business and revenue diversificationDuring the Reporting Period, on top of integrating and improving our existing products, we launched the industry’s first-ever stock learning machine and enriched our small-amount series product matrix for the promotion of revenue diversification. We have formed four main product lines currently, namely “Stock Navigator Series and Super Investor” , “Enjoy-Stock Pad”, “Jiuyao Stocks” and “SmartInvest App” (App). We aim to serve a wider spectrum of customers in a more effective manner by capitalizing on the synergies of these product lines.In order to meet users’ needs, we launched the first “Enjoy-Stock Pad (Starter Edition)” in July to fill the market gap for professional stock learning products. The Company expected that the launch of this product would create a dedicated learning platform for investors, actively fulfil corporate social responsibilities and deepen the inclusive financial education practice. In the meantime, we launched nearly 30 lightweight products to achieve product scalability and standardization, which allowed us to meet the diverse users’ needs and fully explore long-tail customers. During the Reporting Period, our small-amount series products were used by our subscriber customers for more than 2.203 million times.Adherence to pursuing “technological research + investment research” dual-driver strategy, deepening AI technology for full empowerment for the Company’s business and practical applicationImplementing our “technology + investment research” dual-driver strategy, we further increased our R&D investment, explored the empowerment and application of AI and other frontier technologies to the Company’s product offerings, business operations and operational management. With focus on the “buyer-side investment advisory” service, we strengthened our “1+N” investment research system to fully penetrate our investment research into businesses and processes, so as to professionally support our customers in creating long-term value.We continuously strengthened our R&D capabilities and investment: During the Reporting Period, we invested approximately RMB319 million in R&D activities, representing an increase of 10.9% over the Corresponding Period. Such R&D investment accounted for approximately 13.8% of the Company’s total revenue. In addition, as of the end of the Reporting Period, we had 136 software copyrights and patents on product features, big data and AI, that was 52 more than last year. What is noteworthy is that during the Reporting Period, we became a member of the Chinese Association for Artificial Intelligence (CAAI), signifying that the Company has been recognized for its core AI R&D technologies and achievements in the financial sector.We explored the all-round empowerment of AI and other frontier technologies to the Company’s product offerings, business operations and operational management. In terms of empowering our product offerings, we launched “FinSphere Agent”, a new-generation conversational stock investing assistant, and “FinSphere Report”, an intelligent investment research product. They provide deep-thinking intelligent conversational investment advisory services and intelligent research report generation and explanation services. We continuously upgraded our digital investment robo-advisor “Jiu Ge”, served approximately 472,000 customers, with total services reaching 32.407 million times, during the Reporting Period. In terms of empowering our business operations, we deployed our “AI Marketing Partners” and “AI Live Replay Summaries” which enabled us to achieve full-process coverage of text generation and pitch recommendations that doubled our communication efficiency. In terms of empowering our compliance management: The Company developed the intelligent compliance management solution 3.0, with which, our “AI Monitoring Officer” has conducted approximately 1.6 billion monitoring tasks and our “AI Inspection Officer” has assisted in over 10 million review tasks, achieving a coverage rate of 98%.We focused on “buyer-side investment advisory” and emphasized the application of our investment research. In the single month of December, our professional stock review programs output an average of approximately 22 shows per day, with a total duration of nearly 13 hours; we engaged active interactions with investors and answered their questions. The average number of inquiries per day exceeded 2,500. Our JF Financial Research Institute has designed more than 218 sets of self-developed signature courses, with a total of more than 1,300 sessions and a total of over 12,000 minutes, further improving the system of providing courses on our Stock Learning Machine.Establishment of quality traffic system to achieve precise expansion of new customer baseWe established quality traffic system and continued to expand our presence on platforms. During the Reporting Period, apart from our established presence on Douyin and WeChat Channels, we explored Kuai and tapped into platforms such as Xiaohongshu and Bilibili, to achieve high accessibility to customers, increase our brand exposure, optimize our live broadcast efficiency and enhance viewers’ experience through short video + live broadcast approach. The live broadcasts lasted over 49,800 hours cumulatively with 26,500 sessions, representing a growth of over 110% from the Corresponding Period. During the Reporting Period, we operated 152 new MCN accounts on different internet platforms. As of December 31, 2024, we had 526 MCN accounts and attracted approximately 50.05 million followers, as compared to approximately 11.15 million followers in the Corresponding Period.At the same period, we actively promoted popular investor education and enhanced brand influence. At the National Investor Protection Publicity Day on May 15, we organized the “Shareholders Are Here” event jointly with Everbright Securities to attract investors’ participation in the education on rational investing through short videos and live broadcasts on all of the Company’s platforms, together with the active promotion by traditional media such as Hubei TV and China Business Network (CBN). As of December 31, 2024, we have exclusively sponsored CBN’s live broadcast of the Berkshire Hathaway Annual Shareholders Meeting for the fifth consecutive year. We produced the live broadcast program “Buffett and Seven Lunches”, which recorded a total online viewership of nearly 227 million.Business outlookThe chairman of the Board and chief executive officer of JF SmartInvest Holdings Ltd, Mr. Chen Wenbin said: "We will adhere to our principles of rational investing, value investing and long-term investing to help customers induce right investing concepts, practice investor education, fulfil corporate social responsibility and commit ourselves to promoting healthy development of the capital market in the long run. Looking forward to 2025, we, as a next-generation stock investing assistant, will continue to strengthen our competitiveness, solidify our market leadership and strive to make investing and wealth management easier yet more professional, and enhance the happiness of investing and wealth management. "About JF SmartInvest Holdings Ltd (Stock Code: 9636)JF SmartInvest Holdings Ltd is a new generation stock investment assistant. The Company is engaged in the provision of equity investment instruments, securities investment advisory, investor education and other services to individual investors. The products include stock quote software, stock learning machine, Stock Navigator, Super Investor and Jiuyao Stocks. The Company adopts the technology + investment research model, develops JF Robo-Advisor, FinSphere Agent, FinSphere Report and other products based on artificial intelligence (AI) and big data technology, which are applied to the industry in terms of innovative practice and scenario application.For enquiries, please contact:Financial PR (HK) LimitedEmail: ir@financialpr.hkTel: 852 2610 0846Fax: 852 2610 0842 Copyright 2025 ACN Newswire via SeaPRwire.com.

Kuala Lumpur/Bangkok/Singapore , Apr 3, 2025 - (ACN Newswire via SeaPRwire.com) - India is emerging as the world’s next manufacturing giant—yet global corporations still stumble at the entrance. Despite its $7.5 trillion growth trajectory, cost advantages, and policy incentives, there are still several obstacles in the way of building a long-lasting presence in India. A recent whitepaper titled “Why Do Global Manufacturers Struggle with India Market Entry” offers a data-driven blueprint for overcoming regulatory, supply chain, and regulatory obstacles in one of the world’s complex but most promising economies.Regional companies aiming to expand into India can find a powerful roadmap in SRKay Consulting Group’s latest release, “Why Do Global Manufacturers Struggle with India Market Entry” This comprehensive publication outlines the key challenges that often derail even the most experienced players—including regulatory red tape, infrastructure hurdles, intellectual property risks, pricing pressures, and workforce acquisition difficulties.The report dives deep into the root causes behind these obstacles, from fragmented supply chains to complex compliance landscapes, and presents a structured, four-pillar India entry strategy. Covering insights across seven key sectors, it serves as an essential guide for manufacturers seeking to build a resilient and scalable presence in the Indian market.Highlights & Strategic Takeaways:A Proven India Market Entry Framework: A four-pillar approach covering research, business setup, supply chain localisation, and long-term growth.Real Success Stories: What global giants like Apple, Hyundai, and IKEA won in India by adapting to local demand and operational realities.Insights for Emerging Market Entrants: UAE and Malaysia-based companies prioritise India’s growth and competitive costs, but face workforce, regulatory, and IP-related hurdles.Digital & Trade Enablers: How UPI, ONDC, and Free Trade Agreements (like CEPA and ECTA) are creating new competitive advantages for manufacturers.“India is not just a big market—it’s a complex one. For Southeast Asian companies, entering India without the right regulatory, supply chain, and cultural game plan is risky. This whitepaper is our answer to help them succeed,” said Alok Kumar, Founder & Managing DirectorThis whitepaper is an essential resource for business strategists assessing market viability or C-suite executives considering expansion to confidently and clearly navigate the India opportunity.Download the Whitepaper NowWhy Do Global Manufacturers Struggle with India Market EntryAbout SRKay Consulting GroupSRKay Consulting Group is a global consulting firm that helps companies expand into emerging markets like India through data-led strategies, market entry advisory, and operational consulting. With deep expertise in regulatory compliance, digital infrastructure, and supply chain localization, SRKay is the trusted partner for Southeast Asian firms entering India.For expert consultation and partnership opportunities, connect with:Komaldeep KaurEmail: Komal@mianext.com Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年4月3日 - (亚太商讯 via SeaPRwire.com) - 香港领先的品牌保健品营销商及分销商健倍苗苗（保健）有限公司（「健倍苗苗」；股份代号：2161，连同其附属公司统称「集团」）今天公布已完成收购天喜堂药厂有限公司（「天喜堂」）90%股权，总代价为171.0百万港元。天喜堂现正式成为健倍苗苗的非全资附属公司。引入信誉悠久品牌 强化产品组合天喜堂旗舰产品「天喜堂天喜丸」历史悠久，在香港及中国内地（尤其广东省）享有极高的品牌知名度。该产品配方独特，专为调节女性生理周期、促进生殖健康及增强血液循环以提升气色而设，深受女性消费者信赖，被广泛视为妇科健康的可靠良方。集团看好其独特的市场定位及长期增长潜力，是次收购将有效强化集团品牌中药产品组合的战略布局。释放增长潜力及协同效应是次收购为扩展集团的品牌中药组合，并加快其增长策略，提供了一个极佳的机会。通过将此一标志性品牌纳入现有产品线，集团可充分把握市场增长机遇，满足消费者对全人健康解决方案日益增长的需求。为充分发挥品牌潜力，集团计划开展全面的市场推广活动，凭借其成功的品牌管理及年青化经验，提升消费者认知度及参与度。同时，集团将扩展分销网络，把握新市场机遇及拓展新的客户群。透过收购业务的互补优势，是次收购预期可带来显著的协同效应，符合集团收购资产及业务之策略，有助强化其长远愿景及提升股东价值。品牌年青化的成功经验集团对传统中药品牌年轻化拥有丰富经验，成功将将经典产品转化为市场领先品牌。旗下标志性品牌包括肠胃中成药市场的领导品牌「保济丸」、家喻户晓的止痛退烧药品牌「何济公」、以及透过融合香港怀旧情怀与创意广告，成功塑造全新形象的传统中药油品牌「飞鹰活络油」。集团透过策略性品牌重塑、全渠道拓展及数码驱动的消费者互动策略，成功将传统品牌转型为同时深受忠实客户及年轻一代青睐的现代保健解决方案。健倍苗苗将为「天喜堂天喜丸」这个信誉卓著的品牌注入新动力，进一步扩大其市场影响力。健倍苗苗行政总裁黄一伟先生表示：「收购天喜堂是巩固我们在品牌中药板块领导地位的关键举措。凭借其深厚的品牌底蕴及广泛的市场认可度，『天喜堂天喜丸』将为我们的产品组合带来高度互补的协同效应。凭借丰富的品牌重塑经验，集团有信心全面释放该品牌的市场增长潜力，为股东创造长远价值。」有关健倍苗苗（保健）有限公司 （股份代号：2161）健倍苗苗是设于香港的品牌医疗保健品推广及分销公司，产品据点遍及大中华、东南亚及其他选定国家。集团拥有丰富的行销专业知识并具备深厚的制药背景，秉承产品功效和品质至上的优良传统，在行业内定位独特，致力于满足消费者的保健需要。作为本地领先的品牌医疗保健品运营商，集团拥有一广泛系列品牌医疗保健品，包括品牌药、品牌中药及健康保健品，其中包括「保济丸」、「何济公止痛退热散」、「天喜堂天喜丸」、「飞鹰活络油」、「唐太宗活络油」、「十灵油」、「镇痛霸祛风活络油」、「德国秀碧除疤膏」及「美德玛宝儿除疤啫喱」等家喻户晓的传统品牌。而自2021年5月27日，集团获纳入MSCI 香港微型股指数成份股。有关集团详情，请浏览：www.jbmhealthcare.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com.

香港, 2025年4月3日 - (亚太商讯 via SeaPRwire.com) - AEON信贷财务（亚洲）有限公司（"AEON信贷财务"或"集团"；股份代号：00900）今天公布截至二零二五年二月二十八日止年度之全年业绩（"二零二四/二五财年"或"报告年度"）。于报告年度，集团收入较上一年度增长8.4%至1,759,300,000港元，主要得益于集团实施多项营销计划，有效刺激信用卡消费，促使信用卡及私人贷款应收款项稳定增长。收入增长亦归因于费用及佣金收入增长10.4%，这得益于信用卡收单业务交易量的提升，以及保险中介业务新保险产品的推出。随着营运效率提升，成本对收入比率从截至二零二四年二月二十九日止年度（"二零二三/二四财年"或"上一年度"）的46.9%微降至46.6%，在营运层面上及未计入亏损及减值准备前，营运溢利上升9.1%至881,200,000港元。二零二四/二五财年税后溢利增长2.1%至400,500,000港元。董事会建议派末期股息每股25.0港仙（二零二三/二四财年：每股24.0港仙），二零二四/二五财年全年股息为每股49.0港仙，派付股息比率为51.2%。因应市场复苏步伐较预期缓慢，集团于二零二四/二五财年优先考虑稳定销售和应收款项增长，专注于打造着重创造收入、增长和韧性的高质量客户贷款组合。相比上一年度，集团整体销售额再创新高，持续增长10.5%。截至二零二五年二月二十八日，客户贷款及应收款项余额与二零二四年二月二十九日的余额相比增加了5.3%。此外，集团于报告年度内获得由九家地区及本地银行组成的银团所提供三亿港元可持续发展表现挂钩借款，进一步彰显集团将可持续发展理念融入其业务营运的坚定承诺。在市场推广方面，集团与多个业务伙伴合作开展具针对性的营销及推广活动，向目标客群更有效地宣传精心开发的产品及服务之竞争优势。此外，为实现分行网络多元化并满足客户对面对面咨询服务日益增长的需求，集团继续整合及扩充其分行网络，包括于二零二四年六月开设沙田新分行。客户体验方面，升级后的信贷申请处理平台促进了"AEON 香港"手机应用程式（"手机应用程式"）内虚拟信用卡功能的推出，客户可在信用卡获批及启动后立即进行购物。集团亦持续将营运数码转型列为重点工作，其中包括强化客服平台以提升客户互动回应效率。在信贷管理方面，加强后的信贷监控模型纳入了更新的客户信贷使用指标，改善了信贷风险分配，促进和更精准地利用、监控和控制客户组合的信贷风险。与此同时，为进一步巩固集团的科技基础，集团已成功将核心资料中心迁至将军澳，优先考虑运作时间、容错能力及成本效益，该中心亦符合国际认可的绿色建筑认证标准。此外，集团已完成改造综合核心营运系统平台。此等改进措施为未来产品推出及系统升级奠定了更坚实的资讯科技基础架构。展望二零二五年，预计本地消费市场将继续逐步复苏，集团将优先透过海外和线上消费来实现销售额和应收款项的增长。与此同时，集团将改进信贷评估和监测方法，以保持可持续的资产质素组合并加快审批速度。集团一直致力于创新与科技，并始终为客户提供无与伦比的使用体验。未来一年，集团计划开发及实施全新一体化的积分回赠平台，以简化积分管理流程。新的积分平台允许客户在单一平台上无缝管理和累积从 AEON信用卡和其他参与商户获得的积分，以确保易于使用。作为香港负责任的消费金融服务供应商，集团始终致力于将可持续发展理念融入其营运，并将继续推广可持续和数码化的产品和服务，包括即将推出、支持顾客转向低碳生活方式的贷款产品。此外，随着非接触式流动支付在香港的普及，集团将进一步投资开发虚拟卡功能。AEON信贷财务董事总经理魏爱国先生表示："尽管经营环境充满挑战，我们欣然于二零二四/二五财政实现稳健增长，为长期可持续发展奠定坚实基础。适逢AEON信贷财务成立三十五周年，我们始终致力提供以客为本的卓越信用卡服务。集团目标透过推出创新及客制化产品扩大客户群，并于快速发展的消费金融市场中把握新的增长机遇。凭借集团强大的流动性和稳健的资产负债表，我们具备充分优势维持增长动能，推动未来业务持续成功。"关于AEON信贷财务（亚洲）有限公司（股份代号： 00900）AEON信贷财务（亚洲）有限公司为AEON Financial Service Co., Ltd.之附属公司（东京证券交易所代号：8570）及AEON集团旗下公司，成立于1987年，并于1995年在香港联合交易所有限公司主板上市。集团主要从事金融业务，包括于香港签发信用卡及提供私人贷款、信用卡付款处理服务、保险中介业务，以及于中国内地从事小额金融业务。详情请浏览公司网址：www.aeon.com.hk。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港, 2025年4月3日 - (亚太商讯 via SeaPRwire.com) - 中国辣味休闲食品行业龙头企业，卫龙美味全球控股有限公司（"卫龙美味"或"集团"）及附属公司（"集团"）（香港联交所股票代码：09985）公布截至2024年12月31日止12个月（"年内"）之全年业绩。2024年，面对错综复杂的国内外环境，中国消费市场不断呈现出新的快速变化。卫龙美味深度洞察消费者需求，聚焦"多品类"产品策略，持续推进全渠道策略和品牌建设，致力于将中国的传统美食打造成消费者能随时随地享用的休闲食品，满足市场和消费者多元化和个性化的需求。回顾年内，卫龙美味整体业务运营及财务业绩保持良好的增长态势。2024年实现总收入约62.66亿元（人民币，下同），同比增长28.6%，主要得益于集团年内有效实施各项业务发展策略，特别是积极推进全渠道建设和品牌建设，线上线下收入均有稳步提升。受惠年内产能利用率提升，集团录得毛利约30.16亿元，同比增长29.9%，毛利率由上年度47.7%提升0.4个百分点至48.1%。集团年内净利润同比增长21.3%至约10.68亿元，主要由于年内本集团的收入增加。基于集团年内整体业绩表现，董事会建议派发2024年末期股息每股普通股0.11元（人民币，含税，下同），此末期股息连同中期股息，约为集团2024年度净利润的59%。同时，集团董事会建议派发特别股息每股普通股0.18元，约为集团2024年度净利润的40%。合计中期股息、末期股息及特别股息，集团拟全年派息比率高达约99%。产品方面，集团基于"多品类"产品策略深度布局，通过深度消费者洞察，挖掘市场需求，持续提升产品品质和创新能力，围绕"麻辣麻辣"、"魔芋爽"、"小魔女"、"风吃海带"多品类系列产品口味、工艺、包装等方面持续升级和创新，进一步丰富了产品矩阵，满足消费者多元化和个性化的需求，巩固了集团在辣味休闲食品市场的领先地位。渠道方面，集团抓住渠道多元化的趋势，持续推进全渠道策略落地实施，与消费者建立更多的连接。集团持续提升销售团队的专业能力，赋能经销商并加强终端门店的执行力，通过优化门店管理和执行策略，有效提升线下渠道的销售业绩。同时，集团积极布局主流电商平台（如天猫、京东、拼多多）和新兴内容电商平台（如抖音、快手、小红书），通过短视频和直播等各种年轻消费者喜爱的方式，增强品牌互动，提升市场影响力。品牌方面，集团不断深化品牌建设，通过线上线下融合的整合式推广策略持续强化与消费者互动，从而推动品牌的持续年轻化与市场渗透。年内，集团围绕核心大单品"魔芋爽"以及以"小魔女"IP为主要抓手的品牌传播，与手游《蛋仔派对》跨界联名"亲嘴烧"产品，以及"榴槤辣条"主题快闪活动等多元行销活动的玩法，持续推动品牌与新生代消费场景深度融合，从而进一步提升品牌的话题度和整体活力。卫龙美味董事长刘卫平先生表示：2024年是卫龙美味砥砺奋进、有效实施各项业务发展策略、收获成长的一年。面对消费市场不断呈现出新的快速变化，集团坚持以消费者体验为中心，持续开拓市场。新的一年，集团将继续积极关注行业和消费者的变化，持续推进产品升级与创新，深化品牌年轻化策略和全渠道布局策略，并加强供应链、数位化能力和组织团队建设，不断提升经营效率，努力为广大股东和客户创造价值。关于卫龙美味全球控股有限公司卫龙美味全球控股有限公司（"卫龙美味"）是中国领先的集研发、生产及销售为一体的辣味休闲食品企业，拥有强劲的增长势头和颇具影响力的品牌。卫龙美味以传统美食为基础开创了中国调味面制品（俗称"辣条"）行业，于2001年开创出第一根辣条，并引领了辣条行业标准建设。凭借出众的品类拓展能力，本集团已成功扩展至蔬菜制品、豆制品及其它产品等品类，推出了包括魔芋爽、风吃海带、小魔女等大单品。卫龙美味是倍受中国年轻消费者喜爱的休闲食品品牌，拥有有效触达年轻消费者的全渠道销售及经销网路。2024年我们荣登胡润百富颁发的"胡润国潮品牌百强榜"，荣获每日经济新闻颁发的"2024食品饮料行业创新力榜『Z世代』喜爱品牌TOP10"和"2024大消费最具成长公司"以及由中国广告协会颁发的"第31届中国国际广告节青年榜2024大学生喜爱的活力品牌"等二十余项奖项。如欲获得更多资讯，请流览https://www.weilongshipin.com/。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港, 2025年4月3日 - (亚太商讯 via SeaPRwire.com) - 中国国际海运集装箱（集团）股份有限公司（简称"中集集团"或"集团"，股份代号：000039.SZ/02039.HK）欣然公布截至2024年12月31日止12个月（"报告期内"或"年内"）之经审核全年业绩。财务摘要业绩亮点01.海工相关产业盈利改善近9亿：制造分部首次扭亏为盈。中集来福士2024年营收同比增长58%至165.56亿人民币，净利润约2.24亿元，下半年毛利率提升7.8个百分点至12.8%。年内，海洋工程分部新增生效订单同比增长93.5%至32.5亿美金，创历史新高。2）金融及资产管理分部净利润大幅改善近6.4亿人民币：钻井平台自升式平台上租率100%，Deepsea Yantai半潜钻井平台租金上涨超20%；02.集装箱产销创历史新高，分部业绩大幅提升：2024年，集团集装箱标准干箱新箱销量同比大增417.03%；集装箱制造板块净利润同比增长128%至人民币40.9亿元，毛利率逐季攀升；03.道路运输、能源化工液态食品两大核心分部业务稳健经营：2024年中集车辆在中国半挂车市场的销量同比提升12.02%，市场占有率连续六年保持全国第一，营收逆势增长；中集安瑞科水上清洁能源相关业务累计新签订单超人民币100亿元，再创新高；04.有息债务结构持续优化：有息负债率下行至22.4%。截至年底，已完成18.9亿浮动计息美元债置换，优化融资成本。中集集团管理层表示："2024年全球整体经营环境持续错综复杂，竞争加剧。集团持续务实笃行，深耕主业，优化订单品质，各业务板块协调并进，厚植制造业坚实优势，擘画服务业高品质发展新蓝图。得益于不断夯实的全球营运平台基础，集团能够通过捕捉各区域客户需求、平抑单一地区的风险波动，实现稳健有质发展。2024年，集团秉持稳中求进、守正创新的理念，发挥全球布局优势，于逆势中破浪前行，单季度业绩节节攀升，全年实现营业收入1,776.64亿元，同比增长39.01%，创历史新高；归母净利润达29.72亿元，同比大幅增长605.60%；其中，海外与国内营收比重约54%比46%，全方位捕捉区域增长极。"主要板块经营表现（人民币亿元）2024各项指标营业收入占总营收比重毛利占总毛利比重毛利率净利润集装箱制造622.135.0%97.043.6%15.6%40.9物流服务313.917.7%19.48.7%6.2%4.4道路运输车辆210.011.8%34.315.4%16.3%10.8能源、化工 液态食品装备255.814.4%35.315.9%13.8%7.3海洋工程165.69.3%15.16.8%9.1%2.2核心业务表现在物流领域集装箱制造业务再创佳绩，标准箱生产交付量达到历史新高。报告期内，全球商品贸易需求回升，行业权威分析机构克拉克森（CLARKSONS）2025年2月报告显示2024年全球集装箱贸易量同比增长5.9%至2.13亿TEU；同时，红海危机导致欧线绕航、码头工人罢工导致港口拥堵等事件降低了集运运输效率，集装箱需求提升。受此影响，报告期内，集团集装箱制造业务产销量创下历史高峰，其中干货集装箱累计销量达343.36万TEU（去年同期：66.41万TEU），同比增长约417.03%；冷藏箱累计销量13.86万TEU（去年同期：9.25万TEU），同比增长约49.84%。2024年全年集团集装箱制造业务实现营业收入人民币622.05亿元（去年同期：人民币302.13亿元），同比上升105.89%，实现净利润人民币40.88亿元（去年同期：人民币17.94亿元），同比上升127.84%。物流服务业务方面，报告期内，全球商品货物贸易呈现反弹增长态势，带动国际集运市场货量需求旺盛；同时，集运运价大幅回暖，反向促进空运、陆运市场需求增长。2024年集团物流服务业务直接获客能力持续增强，其主要核心产品业务量呈现2%-49%不同程度的增长，实现营业收入人民币313.89亿元（去年同期：人民币201.66亿元），同比增长55.65%，再创历史新高；净利润为人民币4.37亿元（去年同期：人民币1.87亿元），同比增长133.27%。其中，场站业务量再创新高，全年完成空箱进出场箱量超过750万TEU。报告期内，中集世联达在全球物流业权威杂志《Transport Topic》2024年全球海运货代50强榜中位列中国企业第三。道路运输车辆方面，中集车辆纵深掘进"星链计画"，实现新质领航。2024年，尽管全球商用车物流市场表现疲软，但中集车辆星链计画通过整合国内半挂车工厂资源，凭借卓越的产品力突出重围，实现国内车辆销量逆势上扬，巩固海外市场的竞争优势。国内市场方面，中集车辆在中国半挂车市场的销量同比提升12.02%，中国半挂车市场占有率连续六年保持全国第一，营收逆势增长。期内，中集车辆还顺应新能源发展趋势，首次向市场推出了纯电动头挂列车产品。2024年，中集车辆实现收入人民币209.98亿元（去年同期：人民币250.87亿元），同比下降16.30%；实现净利润人民币10.81亿元（去年同期：人民币24.48亿元），同比下降55.83%，主要系2024年北美业务由高位回归常态水准；同时2023年中集车辆处置深圳专用车股权产生一笔非经常性收益约人民币8.48亿元。在能源领域海洋工程方面，业绩首次扭亏为盈。2024年全球船舶和海工市场环境持续向好，国际油价处于相对高位水准，对油气生产平台仍存在促进作用，持续增长的海洋作业活动推动海工装备利用率和租金连续走高，海工装备市场继续恢复向好。报告期内，中集来福士新签海工订单创历史最佳业绩，达32.5亿美金（去年同期：16.8亿美元），同比增长近一倍，包括1条FLNG修改造、2个FPSO船体总包、3条滚装船及其它清洁能源订单。2024年底，累计持有在手订单价值同比增长27%至69.2亿美元（去年同期：54.7亿美元），其中油气业务、风电安装船及滚装船占比约为3：1：1，已排产至2027年。报告期内，集团海洋工程业务的营业收入为人民币165.56亿元（去年同期：人民币104.52亿元），同比上升58.41%；净盈利人民币2.24亿元（去年同期：净亏损人民币0.31亿元）。海工资产运营方面，全球宏观经济复苏缓慢及原油价格波动持续影响全球海上钻井市场，市场竞争加剧，海上钻井市场利用率及费率在下半年有所承压。石油公司重新审视新能源转型，调整发展战略、放慢转型步伐，重新聚焦油气生产。报告期内，中集海工资产运营管理业务持续发挥现有专案经验和业务能力，进一步巩固与国内外客户合作关系，借助优异的海工平台运营管理能力，提高资产上租率，成功完成2座平台新签租约。2024年，海工资产池平台运营抢抓资产盘活机会，租赁运营收入实现同比提升，减亏效果明显。能源、化工及液态食品装备业务方面，集团克服周期错位波动，助力全球能源转型需求。清洁能源收入与订单增速亮眼，更持续完善海外业务布局及氢能上游业务能力。具体来看，全球航运业加速绿色转型，中集安瑞科水上清洁能源相关业务累计新签订单超人民币100亿元，再创新高；LNG车用瓶的销售收入达人民币11.4亿元，同比增长31%，创历史新高。化工环境连续多年全球罐式集装箱市场份额第一。液态食品方面，集团紧抓国内烈酒市场成长机遇，实现分部营业收入同比增长。总的来看，报告期内，集团能源、化工及液态食品装备业务实现营业收入人民币255.79亿元（去年同期：人民币250.26亿元），同比增长2.21%；净利润人民币7.32亿元（去年同期：人民币8.54亿元），同比下降14.31%。未来发展和展望集团管理层表示："展望2025年，集团将继续深化公司五年战略规划，落实"加快构建增长新动能，着力推动高品质发展" 的战略主题，统筹"量"的合理增长与"质"的有效提升，打造"成为高品质的、受人尊敬的世界一流企业"。增长新动能方面，中集将抓住绿色发展、新质生产等重要机遇，积极开拓清洁能源、智慧物流等战略新兴业务布局；兼顾全球化，拓展东南亚、中东等新兴市场区域发展机会；注重核心产品升级与关键技术突破，向产业链更高价值环节进取。聚力高品质发展方面，将更加着重提升品质与效益，实现资源投入回报水准的稳定、可持续增长；加强科技创新与数位化建设，进一步提升产品竞争力；加强战略伙伴联盟与产业协同，建立高品质发展关系。2025年，是中集集团'向高而行'的关键一年，集团将持续勇于直面挑战，不畏艰难险阻，以坚定的步伐砥砺奋进，在逆境中寻求突破，在挑战中铸就新篇，以稳扎稳打的业绩回馈全体股东！"关于中国国际海运集装箱（集团）股份有限公司中集集团是全球领先的物流及能源行业设备及解决方案供应商，产业集群主要涵盖物流领域及能源行业领域，龙头市场地位持续巩固。在物流领域，本集团仍然坚持以集装箱制造业务为核心，孵化出道路运输车辆业务、空港与物流装备/消防与救援设备业务，辅之以物流服务业务及回圈载具业务提供物流专业领域的产品及服务；在能源行业领域，本集团主要从能源/化工/液态食品装备业务、海洋工程业务方面开展；同时，本集团也在不断开发新兴产业并拥有服务本集团自身的金融及资产管理业务。作为一家为全球市场服务的多元化跨国产业集团，中集在亚洲、北美、欧洲、澳洲等地区拥有300余家成员企业，共拥有4家上市公司，客户和销售网路分布在全球100多个国家和地区。2024年，本集团业绩实现营业收入人民币1,776.64亿元，毛利率保持在12.52%，净利润为人民币41.95亿元。2024年，本集团位列2024《财富》中国500强榜单第179名。如欲获得更多资讯，请流览https://www.cimc.com/。 Copyright 2025 亚太商讯 via SeaPRwire.com.